c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
XBI
State Street SPDR S&P Biotech ETF
stock
NYSE
ETF
Market Open
Nov 17, 2026 11:56:33 AM EST
144.32
USD
-1.069%
(-1.56)
3,895,787
Pre-market
Nov 17, 2026 9:14:30 AM EST
147.43
USD
+1.063%
(+1.55)
After-hours
144.24
Bid
144.31
Ask
0.07
Spread
Overview
Options
Company
Exchanges
Shorts
News
News
XBI News
1
/
4
Nov 13, 2026
Day breaks
Nov 17, 2026
10:25 AM EST
Chart of the Day: A Rising Biotech Powerhouse With Significant Upside Potential
·
Barron's
07:59 AM EST
Sellas’ GPS Cuts Death Risk By 41% In Pivotal AML Trial – Firm Eyes FDA Filing In First Half Of 2027
·
Stocktwits
01:38 AM EST
IBRX CEO Reveals Fresh Anktiva Data After Bladder Cancer Trial Win — Says FDA Filing Is Just Weeks Away
·
Stocktwits
Nov 16, 2026
08:54 PM EST
SLS Stock Jumps After-Hours: Retail Eyes Lilly’s Cancer Deal for Valuation Clues — 2 Big Investors Grab Shares
·
Stocktwits
01:50 PM EST
VKTX Stock Gives Back Buyout Speculation-Spurred Gains, Investors Continue To Await Key Obesity Trial Topline Data
·
Stocktwits
05:09 AM EST
FDA Decision Watch: Capricor’s DMD Therapy Faces Make-Or-Break Decision, Savara’s Lung Disease Drug In The Spotlight This Week
·
Stocktwits
02:31 AM EST
SLS, IBRX And IOVA Join Merck And Lilly On BlackRock’s Q3 Buy List — A Vanguard Unit Adds All Of Them Too
·
Stocktwits
Nov 15, 2026
09:25 PM EST
Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist
·
Stocktwits
08:49 PM EST
SMMT Stock Plunges Overnight On FDA Rejection — CAPR Holders Feel The Jitters Ahead Of Their Own FDA Test
·
Stocktwits
Nov 13, 2026
07:54 PM EST
Biotech Dealmaker: Early-Stage Platforms And Tools Draw Capital As Full Buyouts Remain On The Sidelines This Week
·
Stocktwits
12:28 PM EST
IBRX Stock In Focus As Institutional Investor Boosts Stake By Over 15% In Q3 — All Eyes On ImmunityBio’s London Conferences Next Week
·
Stocktwits
Nov 12, 2026
08:20 PM EST
IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites
·
Stocktwits
08:13 PM EST
SLS Stock Surges After-Hours: Sellas Says 'Transformative' Phase 3 AML Results Are Coming This Month
·
Stocktwits
06:13 PM EST
CADL Stock Tumbles 38% After-Hours As Candel Pushes Prostate Cancer FDA Application Timeline To Mid-2027
·
Stocktwits
06:06 PM EST
Bank of America Sees Up to 95% Upside in 2 Stocks
·
GuruFocus
01:04 AM EST
CAPR vs IBRX vs SLS vs IOVA: Whose Insiders Cashed Out The Most — And Who Bought Before A 5X Surge?
·
Stocktwits
Nov 11, 2026
10:52 PM EST
IBRX Stock Eyes Worst Week In Nearly 2 Years — But Anktiva’s Sepsis Trial Potential Fuels Retail Bets On Big Pharma Appeal
·
Stocktwits
12:42 PM EST
CAPR Stock Rallies: Investors Scrutinize Labeling Hints Before FDA Decision On Cell Therapy This Month
·
Stocktwits
Nov 10, 2026
08:35 PM EST
SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%
·
Stocktwits
06:56 PM EST
CAPR Stock Rallies After-Hours As Capricor Reaffirms Deramiocel Confidence Ahead Of Nov. 22 Decision; Says Application In Final Review
·
Stocktwits